De novo HRAS and KRAS mutations in two siblings with short stature and neuro‐cardio‐facio‐cutaneous features
AUTOR(ES)
Søvik, Oddmund
FONTE
BMJ Group
RESUMO
Mutations in genes involved in Ras signalling cause Noonan syndrome and other disorders characterised by growth disturbances and variable neuro‐cardio‐facio‐cutaneous features. We describe two sisters, 46 and 31 years old, who presented with dysmorphic features, hypotonia, feeding difficulties, retarded growth and psychomotor retardation early in life. The patients were initially diagnosed with Costello syndrome, and autosomal recessive inheritance was assumed. Remarkably, however, we identified a germline HRAS mutation (G12A) in one sister and a germline KRAS mutation (F156L) in her sibling. Both mutations had arisen de novo. The F156L mutant K‐Ras protein accumulated in the active, guanosine triphosphate‐bound conformation and affected downstream signalling. The patient harbouring this mutation was followed for three decades, and her cardiac hypertrophy gradually normalised. However, she developed severe epilepsy with hippocampal sclerosis and atrophy. The occurrence of distinct de novo mutations adds to variable expressivity and gonadal mosaicism as possible explanations of how an autosomal dominant disease may manifest as an apparently recessive condition.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2598016Documentos Relacionados
- Cardio‐facio‐cutaneous and Noonan syndromes due to mutations in the RAS/MAPK signalling pathway: genotype–phenotype relationships and overlap with Costello syndrome
- Oculo-facio-cardio-dental syndrome in three succeeding generations: genotypic data and phenotypic features
- Partial monosomy 3q in a boy with short stature, developmental delay, and mild dysmorphic features.
- SOS1 is the second most common Noonan gene but plays no major role in cardio‐facio‐cutaneous syndrome
- X;Y translocation in a girl with short stature and some features of Turner's syndrome: cytogenetic and molecular studies.